INTERNATIONAL PATENT: HANX BIOPHARMACEUTICALS, (WUHAN) LTD. FILES APPLICATION FOR "ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING OX40 AND USES THEREOF"

GENEVA, Aug. 10 -- HANX BIOPHARMACEUTICALS, (WUHAN) LTD. (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073) filed a patent application (PCT/CN2025/075609) for "ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING OX40 AND USES THEREOF" on Jan 29, 2025. With publication no. WO/2025/162471, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KE, Hang (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictWuhan, Hubei 430073), YANG, Tao (Building A8, BioPark II, Jiufeng Yi Road, Hongshan DistrictW...